АНДЕРССОН Борхе С. (US),ТАРРАНД Джеффри (US),ВАЛЬДЕС Бениньо К. (US)
申请号：
RU2016149770
公开号：
RU2016149770A
申请日:
2011.12.16
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
A kind of parenteral pyrrole composition includes the first solvent, by benzyl alcohol and/or the alcohol of acidification such as ethyl alcohol and a such as PEG400 lipophilic component, azoles, or triazole, for example, Itraconazole or posaconazole double solvents are dissolved in first vehicle, i.e., without surfactant, especially nonionic surfactant, and the water with low content, preferably less than 5% water. The composition further can advance into immunocompromized mammals, the preferably mankind in implantation such as physiological saline or 5% or 10% glucose solution with infusion fluid. The microorganism such as yeast and mould that the composition can be used for treating and inhibit infection those of cause to azole, but it, which can extend to other pharmaceutically active agent dissolutions, can be used for treating other kinds of infectious diseases or other diseases, such as pernicious and autoimmune disease.
